Core Scientific (CORZR) Equity Ratio (2020 - 2026)

Core Scientific's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.43 for Q1 2026.

• In Q1 2026, Equity Ratio fell 106.34% year-over-year to 0.43; the TTM figure through Mar 2026 stood at 0.43 (down 106.34% YoY), while the FY2025 annual figure was 0.41, up 35.82% from the prior year.
• Equity Ratio came in at 0.43 for Q1 2026 at Core Scientific, down from 0.41 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.42 in Q1 2022 to a low of 1.78 in Q2 2024.
• A 5-year average of 0.49 and a median of 0.52 in 2023 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio jumped 135.38% in 2022 and slumped 1241.14% in 2023, its largest moves.
• Core Scientific's Equity Ratio stood at 0.51 in 2022, then slumped by 65.39% to 0.84 in 2023, then climbed by 23.77% to 0.64 in 2024, then jumped by 35.82% to 0.41 in 2025, then declined by 3.73% to 0.43 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.43, 0.41, and 0.58 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison